LONDON - Valereum Plc (AQSE: VLRM), a company listed on the Aquis Stock Exchange, has announced the exercise of an option agreement by investment firm Blue Sky Vision LLC. The agreement, initially disclosed on December 16, 2024, involves the subscription of 20 million ordinary shares at a price of £0.10 per share, providing Valereum with £2 million in capital. The completion of the subscription and issuance of the shares is anticipated by the end of January 2025.
The funds are expected to enable Valereum to pursue growth opportunities and innovative projects in emerging markets. Blue Sky Vision, along with its affiliated entities, is known for its strategic investment approach and focus on long-term partnerships. This collaboration aims to offer Valereum strategic advisory, operational support, and the ability to navigate market challenges effectively.
Valereum's CEO, Nick Cowan, commented on the partnership, emphasizing its significance for the company's strategic growth and the acceleration of its vision. Cowan expressed confidence that the partnership would scale the business and deliver value to investors and stakeholders.
The completion of the share subscription is subject to due diligence by First Sentinel Corporate Finance. Additionally, the newly issued shares will be locked up for 12 months, with certain conditions allowing for sales after the first six months, provided they do not exceed the value of the option.
The market is expected to receive further updates from Valereum as developments occur. This news is based on a press release statement from Valereum Plc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.